AEGiS-Reuters: U.S. Firms Urged to Bring AIDS Drugs to Africa

Reuters, Ltd.Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.
Click here to return to Reuters main menu


DonateNow


U.S. Firms Urged to Bring AIDS Drugs to Africa

Reuters NewMedia, Inc. - Wednesday July 23 11:15 AM EDT


HARARE, Zimbabwe (Reuter) - U.S. delegates at an African-American summit have pledged to press U.S. pharmaceutical companies to make expensive AIDS drugs more accessible to Africa's poor.

"We will go back home and efforts will be made to make drugs more available by pressuring drug companies to donate drugs to Africa," Rudolf Jackson of the Morehouse School of Medicine in Atlanta told a workshop on AIDS late Tuesday.

Sub-Saharan Africa has one of the highest rates of HIV cases in the world, and health officials say the virus that causes the deadly AIDS disease is still spreading fast.

Various workshops are running concurrently with the fourth African/African American summit that began Tuesday. African leaders will meet U.S. business executives to try and win trade, investment and economic aid for the world's poorest continent.

The workshop expressed concern at the prevalence of AIDS among people of African descent across the world, saying most had no access to expensive medication that had been found to increase the life span of people living with the disease.

A Kenyan official said AIDS was killing more blacks than whites, with 70 percent of people infected with the HIV worldwide being Africans.

In Zimbabwe, official figures show that 500 people are dying every week from AIDS.


970723
RE970714


Copyright © 1997 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.   Contact Reuters.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .